Neoral conversion in stable thoracic transplant patients leads to dose reduction.
Zaldonis
D B
DB
Division of Cardiothoracic Surgery, University of Pittsburgh Medical Center, PA 15213, USA.
Keenan
R J
RJ
Pham
S M
SM
Kormos
R L
RL
Griffith
B P
BP
D000284:Administration, Oral; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005260:Female; D016027:Heart Transplantation / Q000276:immunology*; D016041:Heart-Lung Transplantation / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016040:Lung Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine